Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Laboratory Testing & Automation 2019

Welcome to the 3rd Annual Laboratory Testing & Automation Virtual Event; a free virtual conference for professionals interested in the most recent technologies for today’s labs. Lab automation is a multi-disciplinary approach benefiting from technologies in the lab that facilitate new and improved processes.

The theme for this year's event is The Lab of the Future Enabled by Microfluidics with the following tracks:

Life Sciences

Droplet Based Microfluidics

Clinical Diagnostics

Empowering Laboratory Automation

Next Generation Sequencing

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global automation community with a high degree of interaction through live-streaming video and chat sessions.

Like the 2018 conference, this event will be produced on our robust virtual platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots most popular t-shirts.

Call for Posters
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2019 Laboratory Testing & Automation Virtual Event. Submit your abstract for free, here.

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.

Oncologists have many options when tasked with treating a patient’s cancer. Unfortunately, many cancer drugs and therapies come with potentially debilitating side effects. As such, it is essential that a doctor track a patient’s response to therapy and change course as early as possible if the therapy is not effective at eradicating cancer cells. Precision, personalized tracking of cancer burden is also critical for monitoring patients in remission so that therapy can be restarted the moment the cancer resurfaces. Digital PCR offers clinicians the necessary tool for absolute quantification and precision tracking of circulating DNA cancer biomarkers. COMBiNATi has developed a novel digital PCR platform consisting of a micro-molded plastic consumable and fully integrated instrument designed to address the specific needs of a routine clinical diagnostic tool. Using a patient-specific assay we have proven the platform’s ability to precisely track a specific cancer patient’s response to therapy and ultimate transition to complete molecular remission.

Learning Objectives:

1. What is meant by "liquid biopsy", "precision cancer monitoring" and "personalized medicine"?
2. What is digital PCR and how can it be used to track a patient's response to therapy or recurrence?

In this seminar, Dr Elvira will talk about the use of droplet microfluidic technologies for drug discovery. Initially, she will discuss the fundamental concepts of droplet microfluidic technologies, how they work, and how droplets function in terms stability and reproducibility. Dr Elvira will then use specific examples from her own research to highlight how these platforms can be used in the context of drug discovery, such as to enable the rapid and reproducible determination of distribution coefficients, to quantify lipid digestion kinetics, and for the formation of droplet interface bilayers, which are very simple artificial cells.

Learning Objectives:

1. Explain the fundamental characteristics of droplet microfluidic technologies
2. Describe some of the types of applications of microfluidic platforms for drug discovery

The ultimate limits of diagnostics in biology are the “quantum” units that convey information, e.g. single nucleic acids, proteins, and cells. Microfluidics has emerged as a powerful tool to compartmentalize single cells and molecules into sub-nanoliter droplets as individual bioreactors to enable sensitive detection and analysis down to this quantum limit. However, the current systems for quantum diagnostics have not been widely adopted, partly due to the requirement of specialized instruments and microfluidic chips to generate uniform droplets and perform adequate manipulations. I will discuss the platforms we are developing to fractionate volumes in simplified, instrument-free ways using 3D-shaped microparticles. Each “lab-on-a-particle” can be analyzed using widely available flow cytometers. These new lab-on-a-particle reagents eliminate the need for specialized new equipment for microfluidic compartmentalization and readout and promise to democratize single-molecule and single-cell technologies.

Learning Objectives:

1. Attendee will become familiar with the current approaches and challenges to measure single cells and single molecules and the advantages of fluid compartmentalization.
2. Attendee will be introduced to the concept of lab-on-a-particle technology to perform assays and unique physical underpinnings of these systems.

Computer vision (CV) has seen rapid growth in many industries, including the life sciences with high-content cell imaging and phenotypic assays. However, many biomolecular and cellular assays today typically rely on conventional readouts like spectrophotometry, fluorimetry, and luminescence. Bioelectronica is developing an integrated sensing and fluid-actuation platform (“BE-Platform”) that combines CV, a lensless imager, chemical reagents, and data science approaches to provide researchers and collaborators with a versatile modern tool for biomolecular and cell-based assays in a single instrument.

The BE-platform detects the size, darkness, morphology, and other multi-dimensional features of objects at 5-50 micron length scales. The generality of this approach enables the BE-platform to perform diverse assays and workflows that traditionally require separate analytical tools. The vision is to provide researchers with a cloud-connected technology that integrates data across multiple assays and multiple sites, allowing new forms of workflow automation.

This talk will present some of the current capabilities of the BE-platform and their early-stage applications:

The attractiveness of 3D printing technology in the microfluidic field is growing, specifically stereolithographic (SLA) type 3D printers, owing to their low cost, versatility, fast and easy micro resolution fabrication capability. The traditional microfabrication method doesn’t allow fast device prototyping that is stand-alone and without the needs of laboratory personnel and equipment. This presentation will introduce the 3D printing based microfabrication of microfluidic devices and engage the third-dimensional control of fluids and cells, which can lead to much quicker and more powerful prototyping and discovery in biomedical sensing and tissue engineering.

Learning Objectives:

1. obtain knowledge and technique of the state-of-the-art 3D printing employed in making the lab on chip/microfluidic device.
2. Gain scientific insight into the biomedical problems that can be solved using 3D microfluidic technology.

With growing standards of patient care, clinical testing laboratory across the world are forced to change the way they manage their laboratory operations. More focus is now given to automation as an automated laboratory reduces the risk of human error and allows laboratory personnel to concentrate on their core laboratory jobs, thereby saving time and money. Automation of laboratory also helps in end-to-end sample and workflow management, assuring traceability of results and maintaining data integrity by following standard laboratory practices.

Automating the clinical data management and testing workflows using the Laboratory Information Management System (LIMS) play a significant role in ensuring faster turnaround time, efficiency, and productivity. Implementation of a LIMS helps laboratories to create a streamlined workflow for following SOPs such as ordering tests, testing procedures, conducting studies etc. to achieve quality clinical outcomes. It enhances the quality and reliability of results. A LIMS can help in full traceability, integrated quality control, and automated results upload from instruments, eliminating transcription errors. Besides, a LIMS following HIPAA, 21 CFR part 11 regulations and GLPs facilitates masking of sensitive personal information based on the role of the user in the organization. It helps to configure electronic signatures for accessing and approving laboratory activities and also maintains an audit trail along with a date and time stamp.

Learning Objectives:

1. Understanding the significance of laboratory automation and information management in following SOPs and meeting regulatory compliance.
2. The role of LIMS in improving clinical testing workflows to achieve faster turnaround time, efficiency, and optimal use of resources.

Tissues in the body are wonderfully organized, with specific arrangements of cells, extracellular matrix, secreted molecules, and fluid flow that synergize that create emergent functions. However, many methods for in vitro cell analysis rely on cell cultures with minimal or no spatial organization, making it difficult to reproduce the dynamics found in vivo.

In this talk, I will introduce the features of working with live, intact samples of ex vivo tissue as a system that is complementary to cell culture, particularly when combined with microfluidics to control the tissue microenvironment. I will give examples of cutting edge devices designed to model local molecular movement through tissue and multi-organ interactions, including a brief case study of a microfluidic model of tumor-induced immunosuppression. Together with methods for real-time imaging and analysis, these technologies offer a host of exciting opportunities to model drug delivery and disease.

Learning Objectives:

1. What are the benefits and limitations of studying live tissue in a microfluidic device?
2. How can microfluidics be used to model local drug delivery and multi-tissue communication ex vivo?

Oncologists have many options when tasked with treating a patient’s cancer. Unfortunately, many cancer drugs and therapies come with potentially debilitating side effects. As such, it is essential that a doctor track a patient’s response to therapy and change course as early as possible if the therapy is not effective at eradicating cancer cells. Precision, personalized tracking of cancer burden is also critical for monitoring patients in remission so that therapy can be restarted the moment the cancer resurfaces. Digital PCR offers clinicians the necessary tool for absolute quantification and precision tracking of circulating DNA cancer biomarkers. COMBiNATi has developed a novel digital PCR platform consisting of a micro-molded plastic consumable and fully integrated instrument designed to address the specific needs of a routine clinical diagnostic tool. Using a patient-specific assay we have proven the platform’s ability to precisely track a specific cancer patient’s response to therapy and ultimate transition to complete molecular remission.

Learning Objectives:

1. What is meant by "liquid biopsy", "precision cancer monitoring" and "personalized medicine"?
2. What is digital PCR and how can it be used to track a patient's response to therapy or recurrence?

With growing standards of patient care, clinical testing laboratory across the world are forced to change the way they manage their laboratory operations. More focus is now given to automation as an automated laboratory reduces the risk of human error and allows laboratory personnel to concentrate on their core laboratory jobs, thereby saving time and money. Automation of laboratory also helps in end-to-end sample and workflow management, assuring traceability of results and maintaining data integrity by following standard laboratory practices.

Automating the clinical data management and testing workflows using the Laboratory Information Management System (LIMS) play a significant role in ensuring faster turnaround time, efficiency, and productivity. Implementation of a LIMS helps laboratories to create a streamlined workflow for following SOPs such as ordering tests, testing procedures, conducting studies etc. to achieve quality clinical outcomes. It enhances the quality and reliability of results. A LIMS can help in full traceability, integrated quality control, and automated results upload from instruments, eliminating transcription errors. Besides, a LIMS following HIPAA, 21 CFR part 11 regulations and GLPs facilitates masking of sensitive personal information based on the role of the user in the organization. It helps to configure electronic signatures for accessing and approving laboratory activities and also maintains an audit trail along with a date and time stamp.

Learning Objectives:

1. Understanding the significance of laboratory automation and information management in following SOPs and meeting regulatory compliance.
2. The role of LIMS in improving clinical testing workflows to achieve faster turnaround time, efficiency, and optimal use of resources.

In this seminar, Dr Elvira will talk about the use of droplet microfluidic technologies for drug discovery. Initially, she will discuss the fundamental concepts of droplet microfluidic technologies, how they work, and how droplets function in terms stability and reproducibility. Dr Elvira will then use specific examples from her own research to highlight how these platforms can be used in the context of drug discovery, such as to enable the rapid and reproducible determination of distribution coefficients, to quantify lipid digestion kinetics, and for the formation of droplet interface bilayers, which are very simple artificial cells.

Learning Objectives:

1. Explain the fundamental characteristics of droplet microfluidic technologies
2. Describe some of the types of applications of microfluidic platforms for drug discovery

The ultimate limits of diagnostics in biology are the “quantum” units that convey information, e.g. single nucleic acids, proteins, and cells. Microfluidics has emerged as a powerful tool to compartmentalize single cells and molecules into sub-nanoliter droplets as individual bioreactors to enable sensitive detection and analysis down to this quantum limit. However, the current systems for quantum diagnostics have not been widely adopted, partly due to the requirement of specialized instruments and microfluidic chips to generate uniform droplets and perform adequate manipulations. I will discuss the platforms we are developing to fractionate volumes in simplified, instrument-free ways using 3D-shaped microparticles. Each “lab-on-a-particle” can be analyzed using widely available flow cytometers. These new lab-on-a-particle reagents eliminate the need for specialized new equipment for microfluidic compartmentalization and readout and promise to democratize single-molecule and single-cell technologies.

Learning Objectives:

1. Attendee will become familiar with the current approaches and challenges to measure single cells and single molecules and the advantages of fluid compartmentalization.
2. Attendee will be introduced to the concept of lab-on-a-particle technology to perform assays and unique physical underpinnings of these systems.

Computer vision (CV) has seen rapid growth in many industries, including the life sciences with high-content cell imaging and phenotypic assays. However, many biomolecular and cellular assays today typically rely on conventional readouts like spectrophotometry, fluorimetry, and luminescence. Bioelectronica is developing an integrated sensing and fluid-actuation platform (“BE-Platform”) that combines CV, a lensless imager, chemical reagents, and data science approaches to provide researchers and collaborators with a versatile modern tool for biomolecular and cell-based assays in a single instrument.

The BE-platform detects the size, darkness, morphology, and other multi-dimensional features of objects at 5-50 micron length scales. The generality of this approach enables the BE-platform to perform diverse assays and workflows that traditionally require separate analytical tools. The vision is to provide researchers with a cloud-connected technology that integrates data across multiple assays and multiple sites, allowing new forms of workflow automation.

This talk will present some of the current capabilities of the BE-platform and their early-stage applications:

The attractiveness of 3D printing technology in the microfluidic field is growing, specifically stereolithographic (SLA) type 3D printers, owing to their low cost, versatility, fast and easy micro resolution fabrication capability. The traditional microfabrication method doesn’t allow fast device prototyping that is stand-alone and without the needs of laboratory personnel and equipment. This presentation will introduce the 3D printing based microfabrication of microfluidic devices and engage the third-dimensional control of fluids and cells, which can lead to much quicker and more powerful prototyping and discovery in biomedical sensing and tissue engineering.

Learning Objectives:

1. obtain knowledge and technique of the state-of-the-art 3D printing employed in making the lab on chip/microfluidic device.
2. Gain scientific insight into the biomedical problems that can be solved using 3D microfluidic technology.

Tissues in the body are wonderfully organized, with specific arrangements of cells, extracellular matrix, secreted molecules, and fluid flow that synergize that create emergent functions. However, many methods for in vitro cell analysis rely on cell cultures with minimal or no spatial organization, making it difficult to reproduce the dynamics found in vivo.

In this talk, I will introduce the features of working with live, intact samples of ex vivo tissue as a system that is complementary to cell culture, particularly when combined with microfluidics to control the tissue microenvironment. I will give examples of cutting edge devices designed to model local molecular movement through tissue and multi-organ interactions, including a brief case study of a microfluidic model of tumor-induced immunosuppression. Together with methods for real-time imaging and analysis, these technologies offer a host of exciting opportunities to model drug delivery and disease.

Learning Objectives:

1. What are the benefits and limitations of studying live tissue in a microfluidic device?
2. How can microfluidics be used to model local drug delivery and multi-tissue communication ex vivo?

Amar Basu is vice-president of engineering research at Bioelectronica, while on entrepreneurial leave from Wayne State University where he is associate professor of electrical and computer engineering and biomedical engineering. He received a BSE and MSE in electrical engineering in 2001 and 2003, an MS in biomedical engineering in 2005, and a Ph.D. in electrical engineering in 2008, all with honors from the University of Michigan-Ann Arbor. His dissertation, at the NSF Center for Wireless Integrated Microsystems, investigated interfacial-tension based microfluidic actuators. In 2008, Amar joined Wayne State University, where he has built a research program in multiphase microfluidics and microelectronics for high-throughput screening health monitoring. His lab has published in a variety of areas including digital assays, droplet microfluidics, manipulation using interfacial tension gradients, droplet trapping with laser-based thermocapillary tweezers, sensing based on interfacial phenomena, and wearable sensors for health monitoring. He has received >$2M in funding, the NSF BRIGE award, and the WSU college of engineering outstanding faculty award. Amar serves on the program committees of the Society of Laboratory Automation and Screening (SLAS), IEEE Transducers, and IEEE Sensors conferences.

Dino Di Carlo received his B.S. in Bioengineering from the University of California, Berkeley in 2002 and received a Ph.D. in Bioengineering from the University of California, Berkeley and San Francisco in 2006. From 2006-2008 he conducted postdoctoral studies in the Center for Engineering in Medicine at Harvard Medical School. He has been on the faculty in the Department of Bioengineering at UCLA since 2008 and now as Professor of Bioengineering serves as the Vice Chair of the Department and as the director of the Cancer Nanotechnology Program in the Jonsson Comprehensive Cancer Center. His research pioneered the use of inertial fluid dynamic effects for the control, separation, and analysis of cells in microfluidic devices. His recent work extends into numerous other fields of biomedicine and biotechnology including directed evolution of cells, cell analysis for rapid diagnostics, mechanomedicine, next generation biomaterials, and phenotypic drug screening. He has also been a leader in technology entrepreneurship: He co-founded five companies that are commercializing UCLA intellectual property developed in his lab (CytoVale, Vortex Biosciences, Tempo Therapeutics, Forcyte, and Ferrologix). Among other honors he received the Presidential Early Career Award for Scientists and Engineers (PECASE) and was elected a Fellow of the American Institute for Medical and Biological Engineering in 2016, was elected a Fellow of the Royal Society of Chemistry (FRSC) in 2014, was awarded the National Science Foundation (NSF) Faculty Early Career Development award and the U.S. Office of Naval Research (ONR) Young Investigator Award, the Packard Fellowship and Defense Advanced Research Projects Agency (DARPA) Young Faculty Award, and received the National Institutes of Health (NIH) Director's New Innovator Award and Coulter Translational Research Award.

David Issadore, PhD

Associate Professor of Bioengineering and Electrical & Systems Engineering, University of Pennsylvania

David is an Assistant Professor of Bioengineering and Electrical and Systems Engineering at the University of Pennsylvania. His research focuses on the integration of microelectronics, microfluidics, nanomaterials and molecular targeting, and their application to medicine. This multidisciplinary approach enables Issadore's lab to explore new technologies to bring medical diagnostics from expensive, centralized facilities, directly to clinical and resource-limited settings for applications including early detection of pancreatic cancer, Tuberculosis diagnosis in patients co-infected with HIV, and prognosis of traumatic brain injury. His academic background in electrical engineering and applied physics (PhD, Harvard 2009) and his research experience in a hospital research laboratory (MGH) have prepared him to work and collaborate effectively on these inherently cross-disciplinary problems.

Megan Dueck earned her Master of Science degree from UC San Diego in Molecular Pathology in 2005 and completed her PhD in Biological Sciences at UC San Diego in August 2016. From 2005 until 2011, she was a lecturer in the UC Berkeley Bioengineering department receiving awards and NSF funding to develop undergrad curriculum interfacing molecular biology with microfluidics. Megan has over 15 years of experience with microfluidic device and assay design. Currently Megan is a co-founder and CSO for an SF Bay Area biotech hardware company working to bring a revolutionary digital PCR platform to market.

Katherine Elvira, MSci, PhD, ARCS

Assistant Professor, Canada Research Chair in New Materials and Techniques for Health Applications, University of Victoria

Dr Katherine Elvira is the Canada Research Chair in New Materials and Techniques for Health Applications and an Assistant Professor in the Department of Chemistry at the University of Victoria, British Columbia. She gained her PhD from Imperial College London in 2012, then worked as a Senior Scientist at ETH Zürich, where she worked on a variety of basic and applied research in microfluidic platforms for applications such as single cell analysis, surfactant kinetics and organic synthesis on a chip. Research in the Elvira group focuses on the formation artificial cells on a chip to analyse and quantify drug transport. More information can be found on her website: http://web.uvic.ca/~kelvira/

Mei He, PhD

Assistant Professor, Department of Chemistry, The University of Kansas

Dr. He is a tenure-track assistant professor at the University of Kansas. She received her Ph.D. degree from the University of Alberta and postdoctoral training from the University of California, Berkeley. She is the vice chair of the ASABE Biosensor program and the Councilor of the American Electrophoresis Society. Dr. He is also the founder of Clara Biotech Inc. and the founder committee for the MidWest 3D technology society. The recent publications from Dr. He's research group in the journal of Lab Chip for studying diagnostic and therapeutic roles of exosomes have been selected as the Most Download Articles of 2016, Inside Cover Story, the Most Accessed Articles, and the Featured Cover Story of 2018. Dr. He is also the Lab on Chip Outstanding Reviewer for the year of 2018 by the Royal Society of Chemistry. One of her publications also received the 2018 SLAS Technology Readers Choice Award. Her research interests include 3D microfabrication of nano-biomaterials, biomedical microfluidic devices and sensing approaches, for designing, programming and monitoring biomimetic immunity, associated with extracellular vesicles-based communications.

Shonali Paul has a rich experience of working in diverse industries including IT, genomics and mass spectrometry. In a career spanning over seventeen years, she has built a long and impressive track record of success in high technology software sales, marketing and professional services, developing operational strategies and directing new business initiatives from conception through execution.
She is the key driver of the development, operations and product teams. She has been the key person responsible for two corporate acquisitions. She is the chair of the Member Relations Committee at ISBER and has over 6 years of experience in the LIMS industry.
Shonali Paul holds an undergraduate engineering degree and is an MBA.

Rebecca Pompano, PhD

Assistant Professor in the Departments of Chemistry and Biomedical Engineering, University of Virginia

Dr. Rebecca Pompano is an Assistant Professor in the Departments of Chemistry and Biomedical Engineering at the University of Virginia, and a member of the Beirne B. Carter Center for Immunology Research. She completed a BS at the University of Richmond in 2005, a PhD in Chemistry in 2011 at the University of Chicago, and postdoctoral studies in the University of Chicago Department of Surgery. Dr. Pompano's research interests center on developing microfluidic and chemical assays to unravel the complexity of the immune response. She pioneered the development of microfluidic tools to study immunity in living tissue samples, merging the benefits of microfluidic cultures with intact tissue structure. For this work, she was named a Lab on a Chip Emerging Investigator in 2018. She received an Individual Biomedical Research Award from The Hartwell Foundation, the national 2016 Starter Grant Award from the Society of Analytical Chemists of Pittsburgh, the 2019 Rising Star award for Cellular and Molecular Bioengineering, and an NIH R01 to support her work. In addition to her research, she is active in advocating for continued funding for education and biomedical research on Capitol Hill and for building inclusive environments for STEM research.

Sponsored By

For information on becoming a sponsor or exhibitor, please click here.

Analytik Jena is a provider of instruments and products in the areas of analytical measuring technology and life science. Its portfolio includes the most modern analytical technology and complete systems for bioanalytical applications in the life science area.
Comprehensive
...
service offerings as well as device-specific consumables and disposables, such as reagents or plastic articles, complete the Group's extensive range of products.

Metrohm offers a complete line of analytical laboratory and process systems for titration, ion chromatography, electrochemistry and spectroscopy. From routine moisture analysis to sophisticated anion and cation quantification, we are ready to help you develop your method and
...
configure the optimum system. Move your analysis from the lab to the production line with our custom process analyzers.

The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

Dr. Datwani joined Labcyte Inc., in 2007 and is responsible for leading internal research programs and managing the advanced developments for the creation of new products and capabilities for the company in the arena of acoustic droplet ejection.
Dr. Datwani has over twenty
...
years of experience directing, managing, inventing and applying cutting edge research and developments in both industry & academia. Prior to Labcyte Inc., Sammy was a Senior Scientist and the Advanced Technologies Group Manager at Eksigent Technologies, LLC (acquired by Danaher Corp.) where he led the technical development for an integrated high performance liquid chromatography on a chip (cHiPLCTM). From 2000 - 2003, Sammy held the position of R&D Engineer in the Advanced Technology Group at Caliper Life Sciences (acquired by Perkin Elmer) and spearheaded the development of the several LabChipTM devices as well as the Library CardTM which married high throughput drug discovery on a microfluidic chip with a high-density reagent storage array.
Sammy graduated with honors from The Johns Hopkins University with a B.S. in Chemical and Biomolecular Engineering. He holds a M.S. degree from The Columbia University in Chemical Engineering with a concentration in Polymer Science. Sammy earned his Ph.D. in Chemical and Biomolecular Engineering from The Johns Hopkins University where his thesis focused both on theory and experiments to gain a fundamental understanding of the adsorption of surfactants, proteins and small molecules to interfaces. Sammy holds several pending and issued patents and has co-authored more than 20 peer-reviewed publications in journals and books. Since 2011, Dr. Datwani has held an appointment as an Adjunct Professor in the Department of Biomedical, Chemical & Materials Engineering at San Jose State University.

Tammy Germini, MBA, MT(ASCP), is the Clinical Pathology Operations Director at Geisinger Health System in Central Pennsylvania. After earning a BS in Medical Technology from the University of North Carolina-Greensboro, she attended Moses H. Cone School of Medical Technology, and
...
was certified by the American Society of Clinical Pathologist in July 1995. She will be receiving her Master's in Business Administration from the University of Scranton in August of 2017. Tammy worked for Spectrum Laboratory Network for 15 years as a Medical Technologist, Supervisor and Stat Lab Manager. She began working for Geisinger Medical Center in 2010 as the Director of Laboratory Excellence then transferred to the Operations Director for Clinical Pathology 5 years ago.

Continuing Education (CME/CE) Support

Please update your information

Certificate of Attendance

Thank you for choosing LabRoots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.
Please see the CE Credits tab if you are interested in Continuing Education Credits. Otherwise, click the button below to receive your Certificate of Attendance